George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Earnings, Trading Statements Calendar - Week Ahead

Thu, 14th May 2015 05:23

UK Earnings, Trading Statements Calendar 
Thursday, May 14 
AggrekoQ1 Interim Management Statement 
3I GroupFull Year Results
British Land CompanyFull Year Results
Hill & Smith HoldingsTrading Statement
ITVInterim Management Statement
Rathbone BrothersQ1 Interim Management Statement 
Old MutualQ1 Interim Management Statement 
Euromoney Instituitional InvestorHalf Year Results 
Rank GroupInterim Management Statement
Restaurant GroupInterim Management Statement
Riverstone EnergyInterim Management Statement
TalkTalk Telecom GroupFull Year Results
Keller GroupInterim Management Statement
Marston'sHalf Year Results 
Merlin EntertainmentsInterim Management Statement
NewRiver RetailFull Year Results
SIGTrading Statement
Vedanta ResourcesFull Year Results
Stobart GroupFull Year Results
GraingerHalf Year Results 
Mitchells & ButlersHalf Year Results 
VesuviusInterim Management Statement
Balfour BeattyTrading Statement
TungstenTrading Statement
Friday, May 15 
TymanInterim Management Statement
Coca-Cola HBC AGQ1 Results
Bovis HomesInterim Management Statement
Monday, May 18 
BlinkxFull Year Results
Industrial Multi Property Trust Q1 Interim Management Statement 
CranswickFull Year Results
e2v TechnologiesFull Year Results
MitieFull Year Results
Babcock InternationalFull Year Results
FutureHalf Year Results
Tuesday, May 19 
Premier FoodsFull Year Results
ICAPFull Year Results
Innovation GroupFull Year Results
VodafoneFull Year Results
BTGFull Year Results
Land Securities GroupFull Year Results
GreencoreHalf Year Results
HomeserveFull Year Results
Paragon Group of CompaniesHalf Year Results
Topps TilesHalf Year Results
Big YellowFull Year Results
Bloomsbury PublishingFull Year Results
VictrexHalf Year Results
Aveva GroupFull Year Results
Circassia PharmaceuticalsInterim Management Statement
Renew HoldingsHalf Year Results
Entertainment OneFull Year Results
Wednesday, May 20 
Hargreaves LansdownInterim Management Statement
Morgan Advanced MaterialsTrading Statement 
RicardoInterim Management Statement
Great Portland EstatesFull Year Results
Intermediate Capital GroupFull Year Results
Marks & Spencer GroupFull Year Results
BurberryFull Year Results
Cable & WirelessFull Year Results
SSEFull Year Results
UK Mail GroupFull Year Results
VecturaFull Year Results
Pennon GroupFull Year Results
Thomas Cook GroupHalf Year Results
Zoopla Property GroupHalf Year Results
Hogg RobinsonFull Year Results
BritvicHalf Year Results
Patisserie HoldingsHalf Year Results
  
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
4 Dec 2020 13:05

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

Read more
30 Nov 2020 09:53

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Read more
30 Nov 2020 08:06

Vectura signs asthma treatment deal with Kinaset

(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.

Read more
20 Nov 2020 08:34

Court denies GSK appeal in Vectura intellectual property dispute

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.

Read more
19 Nov 2020 20:25

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

Read more
28 Sep 2020 15:53

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
15 Sep 2020 17:22

Vectura Revenue Slips But Swings To First Half Profit

Vectura Revenue Slips But Swings To First Half Profit

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
9 Jun 2020 12:04

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

Read more
8 Jun 2020 15:00

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.